Lexicon Pharmaceuticals, Inc. · NASDAQ:LXRX

Invus Global Management, LLC reported a 10.00% stake in Lexicon Pharmaceuticals, Inc. (Schedule 13D/A)

Event Jan 29, 2026 · Filed Feb 2, 2026

Invus Global Management, LLC reported a 10.00% stake in Lexicon Pharmaceuticals, Inc., 42,765,057 shares, with active intent on Jan 29, 2026. Filed Feb 2, 2026 (Schedule 13D/A).

Stake: 10.00%
Shares: 42,765,057
Intent: Active
What changed: Stake changed
Filed together: 18 holders

The filing in full

Holder	Stake	Shares
Invus, L.P.	10.00%	42,765,057
Invus Advisors, L.L.C.	10.00%	42,765,057
Invus Public Equities, L.P.	1.70%	7,362,368
Invus Public Equities Advisors, LLC	1.70%	7,362,368
Invus Global Management, LLC	10.00%	42,765,057
Siren, L.L.C.	10.00%	42,765,057
Avicenna Life Sci Master Fund LP	0.40%	1,538,462
Avicenna Life Sci Master GP LLC	0.40%	1,538,462
Invus US Partners LLC	1.30%	5,451,204
Ulys, L.L.C.	1.60%	6,989,666
Mr. Raymond Debbane	12.00%	51,217,900
Artal Participations S.a r.l.	36.20%	154,734,327
Artal International S.C.A.	36.20%	154,734,327
Artal International Management S.A.	36.20%	154,734,327
Artal Group S.A.	36.20%	154,734,327
Westend S.A.	36.20%	154,734,327
Stichting Administratiekantoor Westend	36.20%	154,734,327
Mr. Amaury Wittouck	36.20%	154,734,327

Source

View original at SEC

Related